Healthcare provider profile · identity verified

Christie Mitchell, CRNP

Nurse Practitioner · DOTHAN, AL · NPI 1528609146

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	266	90
Amlodipine Besylate	Amlodipine Besylate	233	66
Meloxicam	Meloxicam	183	54
Lisinopril	Lisinopril	168	56
Simvastatin	Simvastatin	156	49
Pantoprazole Sodium	Pantoprazole Sodium	151	59
Albuterol Sulfate Hfa	Albuterol Sulfate	146	47
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	141	42
Duloxetine Hcl	Duloxetine Hcl	129	41
Fluticasone Propionate	Fluticasone Propionate	107	48
Omeprazole	Omeprazole	107	38
Levothyroxine Sodium	Levothyroxine Sodium	106	33
Montelukast Sodium	Montelukast Sodium	102	33
Losartan Potassium	Losartan Potassium	100	36
Carvedilol	Carvedilol	87	29
Metformin Hcl	Metformin Hcl	81	33
Metoprolol Tartrate	Metoprolol Tartrate	81	26
Clopidogrel	Clopidogrel Bisulfate	80	27
Hydrochlorothiazide	Hydrochlorothiazide	80	32
Olmesartan Medoxomil	Olmesartan Medoxomil	80	28
Jardiance	Empagliflozin	76	25
Buspirone Hcl	Buspirone Hcl	75	27
Tamsulosin Hcl	Tamsulosin Hcl	74	26
Farxiga	Dapagliflozin Propanediol	70	15
Furosemide	Furosemide	69	25
Prednisone	Prednisone	66	49
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	63	18
Eliquis	Apixaban	58	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	23
Januvia	Sitagliptin Phosphate	54	suppressed
Potassium Chloride	Potassium Chloride	53	15
Celecoxib	Celecoxib	52	15
Metoprolol Succinate	Metoprolol Succinate	52	20
Ezetimibe	Ezetimibe	51	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	16
Pravastatin Sodium	Pravastatin Sodium	43	13
Fenofibrate	Fenofibrate	40	12
Famotidine	Famotidine	39	15
Methocarbamol	Methocarbamol	39	13
Atenolol	Atenolol	37	11
Chlorthalidone	Chlorthalidone	37	12
Dicyclomine Hcl	Dicyclomine Hcl	37	16
Glipizide	Glipizide	36	14
Rosuvastatin Calcium	Rosuvastatin Calcium	36	15
Janumet	Sitagliptin Phos/Metformin Hcl	34	12
Valsartan	Valsartan	34	suppressed
Mometasone Furoate	Mometasone Furoate	32	17
Propranolol Hcl	Propranolol Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Mounjaro	Tirzepatide	30	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	29	suppressed
Linzess	Linaclotide	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Ozempic	Semaglutide	28	suppressed
Trulicity	Dulaglutide	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	17
Bumetanide	Bumetanide	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	12
Cefuroxime	Cefuroxime Axetil	25	20
Lidocaine	Lidocaine	25	11
Ondansetron Hcl	Ondansetron Hcl	25	13
Sertraline Hcl	Sertraline Hcl	25	suppressed
Cefdinir	Cefdinir	24	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	24	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Invokamet	Canagliflozin/Metformin Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	20	suppressed
Bupropion Hcl	Bupropion Hcl	19	12
Dexlansoprazole Dr	Dexlansoprazole	19	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	17	17
Fluconazole	Fluconazole	17	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	12
Baclofen	Baclofen	16	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Mupirocin	Mupirocin	15	13
Ondansetron Odt	Ondansetron	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	13	suppressed
Azithromycin	Azithromycin	13	13
Cephalexin	Cephalexin	13	13
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Naproxen	Naproxen	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Spironolactone	Spironolactone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error